Search

everythinglearnresearchcommunity

for

Search:↓

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Certain metabolites can either protect against or increase the risk of hair loss.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

The fly larvae infestation caused severe skin damage and health issues in Kenyan dogs.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Topical spironolactone effectively treats hair loss in women.

Hidden fungal infections might cause heart disease and clogged arteries.

Notch/CSL signaling controls hair follicle differentiation through Wnt5a and FoxN1.

Hair shedding is an active process that could be targeted to treat hair loss.

Finasteride improves heart function and repairs damage after heart attack in mice.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Skin cysts might help advance stem cell treatments to repair skin.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Plucked hairs can be used instead of skin biopsies to study hair traits because they contain specific cells related to hair.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.